Skip to main content
See every side of every news story
Published loading...Updated

Oligonucleotide CDMO Market to Hit $6.73 Billion by 2029 Amid Surge in Outsourced Gene-Based Drug Manufacturing

Summary by openpr.com
Press release - ABNewswire - Oligonucleotide CDMO Market to Hit $6.73 Billion by 2029 Amid Surge in Outsourced Gene-Based Drug Manufacturing - published on openPR.com

83 Articles

InsideNoVA.comInsideNoVA.com
+82 Reposted by 82 other sources
Center

Oligonucleotide CDMO Market to Hit $6.73 Billion by 2029 Amid Surge in Outsourced Gene-Based Drug Manufacturing

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 70% of the sources are Center
70% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Charleston Gazette-Mail broke the news in Charleston, United States on Friday, April 3, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal